AI assurance in healthcare: what good actually looks like
Beyond the model card. A practical view of what assured clinical AI looks like in 2026, and how to evidence it.
AI assurance in healthcare has matured fast. The conversation has moved on from 'is your model accurate?' to 'can you evidence safe behaviour in real clinical use, over time, across populations?'. Here's what good now looks like.
The six pillars of clinical AI assurance
- Intended use clearly defined, who, what for, with what guardrails
- Training and evaluation data lineage, provenance, consent, representativeness
- Pre-deployment evaluation, clinical performance, bias, edge cases
- Human-in-the-loop design, where the clinician decides, where the model assists
- Post-market monitoring, drift, fairness, real-world performance
- Incident and change management, what happens when the model is updated
Where most products fall short
Pre-deployment evaluation is usually fine. Post-market monitoring is where most products are weak, performance over time, across patient groups and across new sites is rarely instrumented from day one. NHS buyers increasingly ask for this evidence at procurement, not after go-live.
How DigiSafe helps
We help AI and AVT vendors build assurance into the product, not bolt it on. From safety case to monitoring dashboards to incident playbooks, the work that turns a clever model into a clinically deployable one.
Want this applied to your product?
We turn standards like this into evidence packs, safety cases and embedded CSO support, so you can focus on building.
Keep reading
- Standards
DCB0129: Clinical Risk Management for Health IT Manufacturers, explained
What DCB0129 actually requires, why NHS buyers ask for it, and how to build a Safety Case that holds up to scrutiny.
- Standards
DCB0160: Clinical Risk Management for NHS Deployers, explained
DCB0160 is the deployer's responsibility, and it doesn't disappear just because your supplier has DCB0129. Here's what NHS organisations actually need to do.
- Frameworks
DTAC v2: what changed, what NHS buyers look for, and how to prepare
The Digital Technology Assessment Criteria moved to v2 with sharper expectations on clinical safety, AI, accessibility and interoperability. Here's the plain-English version.
